Immune reactions in benign and malignant melanocytic lesions: lessons for immunotherapy.
about
Vulvar vitiligo-like depigmentation and multiple halos of hypomelanosis at the trunk following treatment with imiquimod 5% cream for vulvar condylomata: casual or related events?New insights in segmental vitiligo: case report and review of theories.Characterization of human γδ T lymphocytes infiltrating primary malignant melanomas.Adjuvant immunotherapy of melanoma and development of new approaches using the neoadjuvant approachImmune surveillance of senescent cells--biological significance in cancer- and non-cancer pathologies.Melanoma as a model tumour for immuno-oncology.Combined cytotoxic activity of an infectious, but non-replicative herpes simplex virus type 1 and plasmacytoid dendritic cells against tumour cells.Targeting the hallmarks of cancer with therapy-induced endoplasmic reticulum (ER) stress.Immunohistochemical Analysis of Collagen IV and Laminin Expression in Spontaneous Melanoma Regression in the Melanoma-Bearing Libechov Minipig.Regression in cancer following fever and acute infection.Clinical features and histological findings are potential indicators of activity in lesions of common vitiligo.Halo naevi with associated vitiligo-like depigmentations: pathogenetic hypothesis.Localized depigmentation on genital melanosis: a clue for the understanding of vitiligo.Factors Associated with Development of Vitiligo in Patients with Halo Nevus.Motor nerve conduction velocity is affected in segmental vitiligo lesional limbs.Cutaneous melanoma: From pathogenesis to therapy (Review).Histopathological features of clinical perineural invasion of cutaneous squamous cell carcinoma of the head and neck and the potential implications for treatment.The antibody response against MART-1 differs in patients with melanoma-associated leucoderma and vitiligo.Immune cells in the melanoma microenvironment hold information for prediction of the risk of recurrence and response to treatment
P2860
Q34140536-702A65A7-1675-40F0-9D20-EF00A486CD4DQ34218187-8B88EAD2-4096-4993-BFF9-62A62CF67295Q34493921-35E0F9C8-9171-4FA2-A46C-2132A41C4CE3Q36844314-0C955A87-5B95-46A0-BBBD-571832C0E5D0Q37999302-AA849BA4-01A3-402B-BBEE-236568E6798AQ38037486-C5D65291-0758-4B5B-BE4E-B3736CAB4294Q38850997-129E3C34-5CE2-40FD-B737-D7B5B9FC112BQ38866745-790C8B13-1BCD-47BE-AAA5-A6872AECB02BQ39303132-DAD888C3-4635-40FE-8DC3-50B5AAE56C98Q44497914-2CF301CA-8D7D-400E-9064-3D894A364F89Q45188397-D8F5ED89-1037-413D-89CC-DCB32D0C566AQ45344644-1C4C048D-8AA1-440C-B192-C6F4648EE3E9Q45345764-A65C5BBC-F63C-45DD-86F9-C093265E89B8Q47218642-42153FE6-49BB-4B37-9B18-7AE72037210EQ47874238-90632597-4428-4253-A35D-CA4BABA3B5D3Q52658584-21D9FBC2-19A8-497D-9F29-DDBC03F8F302Q54783843-D9BB4B78-00DF-4494-BBB6-4AB8C940BF09Q55058396-CA75DAA1-DFE9-4D64-810D-EF47D982FECEQ59275946-FA708170-EED1-4371-A846-2CDA3A5C4BAE
P2860
Immune reactions in benign and malignant melanocytic lesions: lessons for immunotherapy.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Immune reactions in benign and malignant melanocytic lesions: lessons for immunotherapy.
@en
Immune reactions in benign and malignant melanocytic lesions: lessons for immunotherapy.
@nl
type
label
Immune reactions in benign and malignant melanocytic lesions: lessons for immunotherapy.
@en
Immune reactions in benign and malignant melanocytic lesions: lessons for immunotherapy.
@nl
prefLabel
Immune reactions in benign and malignant melanocytic lesions: lessons for immunotherapy.
@en
Immune reactions in benign and malignant melanocytic lesions: lessons for immunotherapy.
@nl
P2093
P2860
P1476
Immune reactions in benign and malignant melanocytic lesions: lessons for immunotherapy.
@en
P2093
K V Vermaelen
M M Speeckaert
M Van Gele
N van Geel
R Speeckaert
P2860
P304
P356
10.1111/J.1755-148X.2010.00799.X
P577
2010-11-19T00:00:00Z